Recs

2

Buy Out or Sell Out?

From tiny acquisitions to massive conglomerate combinations, Wall Street's urge to merge remains strong. Some of these deals might generate sought-after synergy, but others could create what Peter Lynch called diworsification -- weakening a business's core competency by grafting on wildly unrelated subsidiaries. How can we tell the good deals from the dealbreakers?

Breaking down the buildup
To help, we'll turn to the 105,000 investors in Motley Fool CAPS. A combination of two companies with high CAPS ratings should bode well for the new firm's future results, while a high-rated company that joins a lower-rated one may benefit one set of investors more than the other.

Despite troubles in the capital markets, the deals won't stop; they simply might involve more stock and less cash. Here's a handful of recently announced deals, and the rating for each participating company on CAPS' five-star scale:

Acquirer

CAPS Rating

Target

CAPS Rating

Deal Price

NRG Energy (NYSE: NRG  )

****

Calpine (NYSE: CPN  )

***

$11.3 billion

Sonus Pharmaceuticals (Nasdaq: SNUS  )

*****

OncoGenex Technologies

NR

$12 million

Emergent Biosolutions (NYSE: EBS  )

****

Protein Sciences

NR

$78 million

19X

NR

CKX (Nasdaq: CKXE  )

**

$80 million

CAPS ratings courtesy of Motley Fool CAPS; NR = not rated.

A bear of a time
Although we've seen a number of deals pending, the first quarter's $736 billion is the smallest global dollar value amount in six years. Still, the total number of deals is up 14%, to more than 9,100 deals. Although volume in the U.S. is down 41%, Russia and China have taken up some of the slack. Nevertheless, this week we've seen a significant drop in the number of deals.

No static likely for this union
Independent power generators are not regulated by the states, like utilities are. With market-based pricing open to them, they're free to use the run-up in energy prices to juice their bottom lines. It's a welcome situation for producers like NRG and Calpine, both of which have been through the bankruptcy wringer after building too many power plants. Now a surging need for electricity generation has made these facilities more economical.

A combined NRG-Calpine entity would have some 45,000 megawatts of generating capacity spread across the country, making it the largest independent power producer. Yet it's also going to force NRG to shed some of its operations in Texas, which has a cap on just how much of the market any one company can control. The merged company would own 24% of the market, but Texas law caps ownership at 20%. Which facilities would ultimately be sold off has yet to be determined, but with a presence in coal-fired, gas-fired, and geothermal plants, the forced divestment of about 4,000 megawatts shouldn't impede the company's progress at all.

Even before the merger news, investors felt that the post-bankruptcy Calpine was a worthy investment. With rising energy prices, a financial house in order, and an attractive price, investors like CAPS player sssenator saw opportunity:

Buy low, Sell High. This company has just made their way out of the valley of the shadow of bankruptcy. Natgas prices are on the rise, decent balance sheet and a good P/E ratio. I'd expect them to work their way up to their old time prices within a few years.

Now that the offer has been made public, others like leebern see the potential emergence of a premier energy play:

Strong company by itself post-bankruptcy. Poor credit rating is offset by a low P/E ratio, large sums in the bank, and potential merger with NRG to make it the largest independent power company in the country.

A value-added offer
What's your take on these deals? At Motley Fool CAPS, your opinion as valuable as the pros'. Tell the CAPS community whether the urge to merge is good to go -- or whether you think it's better for the firms involved to remain independent.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 655501, ~/Articles/ArticleHandler.aspx, 2/14/2012 2:51:26 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 12,874.04 72.81 0.57%
S&P 500 1,351.77 9.13 0.68%
NASD 2,931.39 27.51 0.95%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/13/2012 4:01 PM
NRG $17.08 Down -0.24 -1.39%
NRG Energy, Inc. CAPS Rating: *****
EBS $17.11 Down -0.24 -1.38%
Emergent BioSoluti… CAPS Rating: *****
CKXE $5.51 Down +0.00 +0.00%
CKX, Inc. CAPS Rating: **

Advertisement